![David Wambeke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Wambeke
Plus aucun poste en cours
Fortune : 7 M $ au 31/05/2026
Profil
David John Wambeke worked at Craig-Hallum Capital Group LLC from 2007 to 2023, including the role of Partner & Managing Director in 2023.
From 2023 to 2025, worked at DiaMedica Therapeutics, Inc. as Chief Business Officer.
Attended the University of Minnesota for undergraduate studies.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/06/2025 | 527 114 ( 0,98 % ) | 3 M $ | 31/05/2026 | |
| 01/06/2024 | 527 114 ( -.--% ) | 3 M $ | 31/05/2026 | |
NeuroOne Medical Technologies Corp.
 NeuroOne Medical Technologies Corp. Medical SpecialtiesHealth Technology Develops thin film electrode technology for epileptic patients 1,93 % | 01/03/2026 | 166 667 ( 1,93 % ) | 591 668 $ | 31/05/2026 |
INEO Tech Corp.
 INEO Tech Corp. Advertising/Marketing ServicesCommercial Services Operates location-based advertising, analytics and theft detection platform for retailers 1,86 % | 17/02/2026 | 6 031 000 ( 1,86 % ) | 60 310 $ | 31/05/2026 |
Anciens postes connus de David Wambeke
| Sociétés | Poste | Fin |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Corporate Officer/Principal | 01/10/2025 |
Craig-Hallum Capital Group LLC
 Craig-Hallum Capital Group LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/03/2023 |
Formation de David Wambeke
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Craig-Hallum Capital Group LLC
Craig-Hallum Capital Group LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
